Study Overview and Methodology
The study, published in the Global Spine Journal (2026), compared the cost-effectiveness of minimally invasive tubular decompression (MIS) and open laminectomy for treating pure lumbar spinal stenosis (LSS) using a Markov state-transition model. The research aimed to evaluate long-term outcomes and economic implications from the U.S. payer perspective over a 10-year horizon. The model simulated a cohort of 10,000 patients aged 65 with pure LSS, defined as no spinal instability, deformity, spondylolisthesis, or prior surgery. Outcomes were measured in quality-adjusted life-years (QALYs) and costs, with 3-month cycles and 3% annual discounting. The analysis incorporated data on perioperative complication rates from the Nerland 2015 propensity-matched cohort, where MIS had a 10.6% complication rate versus 14.6% for open laminectomy. Key parameters like recurrence rates, postoperative utility, and mortality were equalized across both groups due to limited long-term comparative data.
Key Findings and Cost-Effectiveness Results
The study found that MIS tubular decompression resulted in 5.95 QALYs at a cost of $26,283 per patient, compared to 5.91 QALYs at $30,450 for open laminectomy. This made MIS the dominant strategy, saving $4,167 per patient. Cost-effectiveness was observed in 81% of probabilistic sensitivity analyses (PSA) at $50,000/QALY and 82% to 88% under wide-uncertainty sampling. MIS remained cost-effective at $100,000/QALY unless its complication rate exceeded 17.5%. Even without a complication advantage, MIS saved $3,454 while maintaining equivalent QALYs. The QALY gain was attributed to the 4-percentage-point reduction in perioperative complications (10.6% vs. 14.6%), while cost savings stemmed from lower index and revision costs. However, the authors noted that these findings depend on the observed complication difference, which was not statistically significant in the matched analysis.
Limitations and Contextual Considerations
The study’s conclusions are conditional on the assumption that the 4-percentage-point reduction in complication rates between MIS and open laminectomy is reliable. The authors acknowledged that this difference was not statistically significant in the Nerland 2015 cohort, and the model’s results are sensitive to variations in this parameter. Additionally, long-term outcomes such as recurrence rates, postoperative utility, and mortality were equalized across both groups due to a lack of decompression-specific comparative data. The analysis also excluded factors like patient preferences, indirect costs, and broader healthcare system impacts. While the model was designed to be conservative, the authors emphasized that its findings should inform, not dictate, coverage policies. Further research is needed to validate these results in diverse clinical settings and longer-term follow-up.
Implications for Clinical Practice and Policy
The study suggests that MIS tubular decompression may offer a cost-effective alternative to open laminectomy for patients with pure LSS, particularly when considering lower complication rates and reduced immediate costs. However, the authors caution that these findings are not definitive and should be interpreted within the context of existing evidence. The results highlight the importance of balancing short-term cost savings with long-term outcomes, such as reoperation rates and functional recovery. Clinicians and policymakers should consider these findings alongside other studies, including meta-analyses showing mixed results on reoperation rates and complication profiles. The study underscores the need for continued research to refine cost-effectiveness models and better understand the long-term benefits of minimally invasive techniques in spinal surgery.
Conclusion and Recommendations
In conclusion, the study found that MIS tubular decompression was cost-effective compared to open laminectomy for pure LSS, with lower costs and slightly higher QALYs in the base case. However, the results depend on the observed complication difference, which remains unproven in randomized trials. The authors recommend that these findings be used to guide, rather than determine, coverage decisions, emphasizing the need for further research to confirm the long-term benefits and cost-effectiveness of MIS. They also note that while the model was conservative, real-world outcomes may vary based on patient populations, surgical techniques, and healthcare system factors. Future studies should address gaps in long-term data and explore the impact of MIS on broader healthcare economics, including patient-reported outcomes and quality of life metrics.